APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Consistent with the DHE staining, the AO staining revealed a significantly lower apoptotic cell death in the wounded tissue treated with apoA-I:CIGB-258 than only the CML-treated wound (Figure 7A,C).